Nathan Collins

Head of Strategic Alliances, Synfini Inc.

Nathan Collins is listed as Head of Strategic Alliances, Synfini Inc.. Nathan is scheduled to speak at SLAS 2027 International Conference & Exhibition on 31 January 2027.

Compiled from published conference agendas; not yet confirmed by Nathan. Is this you? Claim this profile.

About

Nathan Collins, Ph.D. is the Head of Strategic Alliances of Synfini, the Agile Chemistry Company. He has over 20 years of experience building and scaling new technologies in biotech and pharma with his most recent prior roles as Chief Strategy Officer for life sciences and Vice President of drug discovery at SRI International, where he co-developed the Synfini AI and automation platform. Nathan has led strategy, partnerships, and commercialization efforts across small molecule and biologics drug discovery, molecular design, and emerging life-science technologies, working at the interface of automation, AI, and experimental science. Successfully guiding novel technologies from early-stage innovation to market impact, Nathan bridges science and business to unlock new opportunities in therapeutics and discovery technologies.

Upcoming

SLAS 2027 International Conference & Exhibition 30 January 2027 – 3 February 2027

Operationalizing DMTA: From Implementation to Continuous Optimization Speaker · 31 January 2027

Spoke alongside

People who have shared a session with Nathan at events on B2DB.

Philip Hopcroft Associate Principal Scientist · Astrazeneca 1 shared session
Ruth Petersen Partner, Strategic Advisor · Summit Success Group 1 shared session